Kestra Medical officer proposes $1.05M share sale

The proposed transaction is described as a broker-assisted cashless exercise.

Rhea-AI Filing Summary

KESTRA MEDICAL TECHNOLOGIES, LTD. officer Mahboob Vaseem reported a proposed sale of 34,809 common shares on October 27, 2026, with a listed aggregate market value of $1,045,784.87. The notice associates the shares with exercise of employee stock options and lists five prior common-stock sales dated July 30 through August 7, 2026.

Key Figures

Proposed shares for sale: 34,809 shares Aggregate market value: $1,045,784.87 Prior common-stock sale: 3,980 shares; $90,560.62 +4 more

7 metrics

Proposed shares for sale 34,809 shares October 27, 2026

Aggregate market value $1,045,784.87 Proposed sale

Prior common-stock sale 3,980 shares; $90,560.62 July 30, 2026

Prior common-stock sale 8,817 shares; $199,344.62 July 31, 2026

Prior common-stock sale 5,391 shares; $128,312.27 August 3, 2026

Prior common-stock sale 6,995 shares; $172,634.70 August 4, 2026

Prior common-stock sale 26,287 shares; $680,383.99 August 7, 2026

Key Terms

Rule 144, employee stock options, Broker assisted cashless exercise

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

employee stock options financial

"Exercise of employee stock options"

Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.

Broker assisted cashless exercise financial

"Broker assisted cashless exercise"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KMTS shares did Mahboob Vaseem propose to sell?

Mahboob Vaseem, identified as an officer, listed 34,809 common shares for sale on October 27, 2026, with an aggregate market value of $1,045,784.87. The shares are associated with exercise of employee stock options.

What recent KMTS stock sales are listed for Mahboob Vaseem?

The past-three-month section lists sales of 3,980 shares for $90,560.62 on July 30, 2026; 8,817 shares for $199,344.62 on July 31, 2026; 5,391 shares for $128,312.27 on August 3, 2026; 6,995 shares for $172,634.70 on August 4, 2026; and 26,287 shares for $680,383.99 on August 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/27/2026 - 04:12 PM EDT Accepted by SEC EDGAR 10/27/2026 - 04:12 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001655157
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KESTRA MEDICAL TECHNOLOGIES, LTD.
SEC File Number	001-42549
Address of Issuer	3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WASHINGTON 98033
Phone	(425) 279-8002
Name of Person for Whose Account the Securities are To Be Sold	Mahboob Vaseem
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	34809	1045784.87	59561795	10/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/27/2026	Exercise of employee stock options	KESTRA MEDICAL TECHNOLOGIES, LTD.			34809	10/27/2026	Broker assisted cashless exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/30/2026	3980	90560.62
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	07/31/2026	8817	199344.62
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	08/03/2026	5391	128312.27
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	08/04/2026	6995	172634.70
Vaseem Mahboob 3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WA 98033	Common Stock	08/07/2026	26287	680383.99

144: Remarks and Signature

Remarks
Date of Notice	10/27/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/05/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Vaseem Mahboob
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)